🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a 12-week, multicenter, randomized, double-blind, placebo-controlle...
Status
Terminated
Location
Phoenix
Start Date
2017-03-27
Trial ID
NCT03062540
Treatments Being Tested
This is a 12-week, multicenter, randomized, double-blind, placebo-controlle...
Status
Terminated
Location
Ashild Peters
Start Date
2019-03-07
Trial ID
NCT03841773
Treatments Being Tested
Very low dose (VLD) cyclobenzaprine at bedtime has shown promise as a treat...
Status
Completed
Location
PharmaNet, Inc.
Start Date
2013-06
Trial ID
NCT01889173
This is a Phase 3, open-label, extension trial designed to evaluate the lon...
Status
Completed
Location
Multiple Locations
Start Date
2015-08-04
Trial ID
NCT02589275
Treatments Being Tested
The purpose of this study is to determine if a stepped-care intervention ma...
Status
Completed
Location
Richard Roudebush VA Medical Center, Indianapolis
Start Date
2007-12
Trial ID
NCT00386243
TNX-102 SL has recently been approved by the United States (US) Food and Dr...
Status
Active Not Recruiting
Location
Syneos Health Clinique, Inc.
Start Date
2025-12-09
Trial ID
NCT07413367
Treatments Being Tested
Very low dose (VLD) cyclobenzaprine at bedtime has shown promise as a treat...
Status
Completed
Location
PharmaNet, Inc.
Start Date
2012-06
Trial ID
NCT01634412
This was an open-label, extension trial designed to evaluate the long-term ...
Status
Completed
Location
Denver
Start Date
2013-12
Trial ID
NCT02015234
Treatments Being Tested
Evaluate the long-term safety of TNX-102 SL 5.6 mg taken daily at bedtime o...
Status
Completed
Location
Little Rock
Start Date
2018-04-19
Trial ID
NCT03508700
Treatments Being Tested
The researchers are comparing two treatments for high tone pelvic floor dys...
Status
Recruiting
Location
University of Michigan
Start Date
2026-02-18
Trial ID
NCT07404397
Treatments Being Tested